Maxalt Frequency Guidelines
Maxalt (rizatriptan) should be limited to no more than 10 days per month to avoid medication overuse headache, with individual doses separated by at least 2 hours and a maximum of 30 mg (three 10-mg doses) in any 24-hour period 1.
Critical Frequency Limitations
Within 24 Hours
- Minimum interval between doses: 2 hours 1
- Maximum daily dose: 30 mg total (equivalent to three 10-mg tablets or six 5-mg tablets) 1
- Special consideration for propranolol users: Maximum of 15 mg total (three 5-mg doses) in 24 hours 1
Monthly Usage Threshold
The most important limitation is monthly frequency, not just daily dosing. The 2025 American College of Physicians guideline explicitly warns that triptans (including rizatriptan) used ≥10 days per month lead to medication overuse headache 2. This represents a critical threshold where the medication itself perpetuates the headache disorder.
Medication Overuse Headache Risk
Medication overuse headache develops when:
- Headaches occur ≥15 days per month for at least 3 months
- This pattern develops specifically because of overuse of acute medication
- For triptans specifically, the threshold is ≥10 days per month (lower than the ≥15 days/month threshold for NSAIDs) 2
This is a critical distinction—triptans have a lower threshold for causing medication overuse headache compared to other acute migraine treatments.
Clinical Algorithm for Frequency Management
If treating ≥4 migraine attacks per month:
- Consider adding preventive medications rather than increasing acute treatment frequency 2
- The safety of treating more than 4 headaches in a 30-day period has not been established 1
If patient requires frequent dosing:
- First, optimize the acute treatment regimen (ensure adequate dosing, consider combination with NSAID or acetaminophen) 2
- If still inadequate, add migraine prophylaxis rather than increasing triptan frequency 2
- Monitor monthly triptan usage carefully to stay below 10 days/month threshold
Redosing for Same Attack
- If initial dose provides relief but headache recurs: A second dose may be taken at least 2 hours after the first dose 1
- If no response to first dose: Do not take a second dose without consulting your doctor 1
- Research shows that redosing for recurrent headache after initial benefit achieved 71-82% relief rates with rizatriptan versus 44-54% with placebo 3
Common Pitfall to Avoid
The major clinical error is focusing only on the 24-hour maximum (30 mg/day) while ignoring the monthly frequency limit of <10 days per month. Patients who consistently use Maxalt 2-3 times weekly are at high risk for medication overuse headache, even if they never exceed daily limits. This transforms episodic migraine into chronic daily headache, significantly worsening quality of life and requiring medication withdrawal for resolution.